US 8350079
Treprostinil formulation
granted A61PA61P11/00A61P11/06
Quick answer
US patent 8350079 (Treprostinil formulation) held by United Therapeutics Corporation expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P13/12, A61P21/00